About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by MediWound Ltd.

< Previous 1 2 3 Next >
News headline image
MediWound to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx® Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound to Report Third Quarter 2024 Financial Results
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound to Participate in the 2024 Maxim Healthcare Virtual Summit
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound to Report Second Quarter 2024 Financial Results
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Announces $25 Million Strategic Private Placement Financing
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Reports First Quarter 2024 Financial Results and Provides Company Update
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound to Report First Quarter 2024 Financial Results
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound to Report Fourth Quarter and Full Year 2023 Financial Results
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound to Participate in Two Upcoming Investor Conferences
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer
From MediWound Ltd.
Via GlobeNewswire
Tickers ENLV MDWD
News headline image
MediWound to Report Third Quarter 2023 Financial Results
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Receives Positive CHMP Opinion Recommending Approval for NexoBrid® to Treat Pediatric Patients
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Announces a Collaboration with PolyMedics Innovations (PMI) for NexoBrid® Distribution in Europe
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
News headline image
MediWound Announces Collaboration with 3M on EscharEx® Phase III Study
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD MMM
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.